http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014122351-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_602403e72a1bea0f83f0c41e2a1c4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23ab1447f5733b78766913de8f3495b5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-21
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
filingDate 2014-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_432098707e4f2cf8080e7ea1d412270d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a65e0bc91dff40105a7c5a230f7d38b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06d465f525abb8cbac86338287c65bb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc2f52a2d10645cd96dbeb6644c0b75d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_761471bea2900e9399af1ea8083d0b8e
publicationDate 2014-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014122351-A1
titleOfInvention Use of granulysin for treating solid tumours
abstract The invention relates to the use of granulysin or a nucleic acid molecule that encodes for granulysin, for producing a pharmaceutical composition for treating a solid cancerous tumour of a localised hematological tumour that can be treated intratumourally, wherein the pharmaceutical composition is locally administered, more concretely intratumourally administered. Furthermore, the invention tackles the problem of producing sufficient quantities of active and correctly folded granulysin that allow the use thereof as a pharmaceutical composition in mammals, preferably in humans.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020020978-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2738926-A1
priorityDate 2013-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013011366-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012195854-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006088945-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433197

Total number of triples: 34.